Chemoprevention of Gastric Cancer: Metformin
Metformin is a first-line anti-diabetic drug that has been widely used in patients with type 2 diabetes. Many population-based epidemiologic studies have shown that metformin treatment is associated with decreased risk for various cancers. Recent epidemiologic studies showed that the use of metformi...
Saved in:
| Main Authors: | Young-Il Kim, Soo-Jeong Cho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean College of Helicobacter and Upper Gastrointestinal Research
2017-12-01
|
| Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
| Subjects: | |
| Online Access: | http://www.helicojournal.org/journal/view.html?doi=10.7704/kjhugr.2017.17.4.179 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemoprevention of Gastric Cancer: Helicobacter pylori Eradication
by: Eun Jin Kim, et al.
Published: (2017-12-01) -
Chemoprevention of Gastric Cancer: Statins
by: Sang Hyeon Choi, et al.
Published: (2017-12-01) -
Chemoprevention of Gastric Cancer: Non-steroidal Anti-inflammatory Drugs Including Aspirin
by: Kee Don Choi
Published: (2017-12-01) -
Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study
by: Eun Hye Oh, et al.
Published: (2025-04-01) -
Metformin for the chemoprophylaxis of cancer: an update systematic review about the role of metformin in cancer prevention.
by: Mirella Nardo, et al.
Published: (2020-01-01)